Legend Biotech Corp Stock Price Prediction
| LEGN Stock | USD 42.69 1.75 4.27% |
Oversold Vs Overbought
31
Oversold | Overbought |
EPS Estimate Next Quarter (0.34) | EPS Estimate Current Year (1.38) | EPS Estimate Next Year (0.56) | Wall Street Target Price 82.5485 | EPS Estimate Current Quarter (0.42) |
Using Legend Biotech hype-based prediction, you can estimate the value of Legend Biotech Corp from the perspective of Legend Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Legend Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Legend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Legend Biotech after-hype prediction price | USD 40.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Legend |
Legend Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Legend Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Legend Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Legend Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Legend Biotech Estimiated After-Hype Price Volatility
In the context of predicting Legend Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Legend Biotech's historical news coverage. Legend Biotech's after-hype downside and upside margins for the prediction period are 37.75 and 44.13, respectively. We have considered Legend Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Legend Biotech is very steady at this time. Analysis and calculation of next after-hype price of Legend Biotech Corp is based on 3 months time horizon.
Legend Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Legend Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Legend Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 3.19 | 0.00 | 0.00 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
42.69 | 40.94 | 0.00 |
|
Legend Biotech Hype Timeline
Legend Biotech Corp is now traded for 42.69. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Legend is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.47%. %. The volatility of related hype on Legend Biotech is about 47850.0%, with the expected price after the next announcement by competition of 42.69. About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.92. Legend Biotech Corp had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Legend Biotech Basic Forecasting Models to cross-verify your projections.Legend Biotech Related Hype Analysis
Having access to credible news sources related to Legend Biotech's direct competition is more important than ever and may enhance your ability to predict Legend Biotech's future price movements. Getting to know how Legend Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Legend Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.20) | 6.21 | (9.35) | 34.87 | |
| HCWB | HCW Biologics | 0.01 | 5 per month | 7.39 | 0.1 | 22.00 | (13.64) | 352.85 | |
| SCPH | Scpharmaceuticals | (0.1) | 7 per month | 0.00 | (0.20) | 4.30 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | (0.01) | 6 per month | 1.60 | 0.1 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.68 | (0.02) | 10.00 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.05) | 6 per month | 2.60 | 0.11 | 6.35 | (5.19) | 26.13 |
Legend Biotech Additional Predictive Modules
Most predictive techniques to examine Legend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Legend using various technical indicators. When you analyze Legend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Legend Biotech Predictive Indicators
The successful prediction of Legend Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Legend Biotech Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Legend Biotech based on analysis of Legend Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Legend Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Legend Biotech's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 14.37 | 17.19 | 21.69 | 22.78 | Receivables Turnover | 1.78 | 2.57 | 1.82 | 1.06 |
Story Coverage note for Legend Biotech
The number of cover stories for Legend Biotech depends on current market conditions and Legend Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Legend Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Legend Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Legend Biotech Short Properties
Legend Biotech's future price predictability will typically decrease when Legend Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Legend Biotech Corp often depends not only on the future outlook of the potential Legend Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Legend Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 176.1 M | |
| Cash And Short Term Investments | 1.3 B |
Check out Legend Biotech Basic Forecasting Models to cross-verify your projections. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 2.851 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.28) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.